ad image

Reagents

1 / 1
Ampersand Capital Partners
Acquisition

Ampersand Capital Partners Aquired Nektar Therapeutics' PEG Reagent Manufacturing Business, Launching Newly Branded Gannet BioChem

Ampersand Capital Partners

PR-12-24-NI-121Dec 02, 2024
Accelerating Large Molecule Drug Development
CRO

Accelerating Large Molecule Drug Development

Haematologic Technologies

PAO-02-22-R250-20Feb 27, 2022
1 / 1